Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | MVD | P53602 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.31 |
| ▸ | CPT2 | P23786 | 1/20 | 0.31 |
| ▸ | HMGCR | P04035 | 1/20 | 0.31 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.31 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.31 |
| ▸ | ACLY | P53396 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28036003 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL10437619 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL6695579 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL17559293 | 1.00 | ALDH1A1 (0.36) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Water SCHEMBL16061866 | 0.98 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Water SCHEMBL15510736 | 0.98 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Water SCHEMBL15092995 | 0.98 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Water SCHEMBL12004445 | 0.98 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| Water SCHEMBL12004446 | 0.98 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A | |
| SCHEMBL27524295 | 0.98 | ALDH1A1 (0.34) | ALDH1A1TSHRCYP2D6CYP2C19HIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114451462-A | Beef tallow aroma enhancement method based on enzymolysis technology | 广汉市迈德乐食品有限公司 | 2022-05-10 | — | — | CN | claimed |
| CN-109608081-B | Synergist for reducing stone powder adsorption performance in siliceous machine-made sand and preparation method thereof | 北京科技大学 | 2020-09-29 | — | — | CN | claimed |
| EP-2470877-B1 | METHOD AND APPARATUS FOR ANTIGEN RETRIEVAL PROCESS | GEN ELECTRIC (US) | 2020-06-03 | — | — | EP | claimed |
| CN-109195629-A | Influenza antibody molecular preparation | 威特拉公司 | 2019-01-11 | — | — | CN | claimed |
| EP-2685973-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCULOSKELETAL RELATED DISEASES AND DISORDERS USING METAL ION-CITRATE ANALOG COMPLEXES | The Charlotte-Mecklenburg Hospital Authority D/B/A (US) | 2014-01-22 | — | — | EP | claimed |
| US-20120238521-A1 | Compositions and Methods for the Treatment of Musculoskeletal Related Diseases and Disorders Using Metal Ion-Citrate Analog Complexes | The Charlotte-Mecklenbury Hospital Authority d/b/a Carolinas Medical Center (US) | 2012-09-20 | — | — | US | claimed |
| WO-2012125524-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MUSCULOSKELETAL RELATED DISEASES AND DISORDERS USING METAL ION-CITRATE ANALOG COMPLEXES | THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY D/B/A CAROLINAS MEDICAL CENTER (US) | 2012-09-20 | — | — | WO | claimed |
| WO-2009077210-A1 | MONETITE MATRICES AND THEIR APPLICATION IN BONE REGENERATION | UNIVERSIDAD COMPLUTENSE DE MADRID (ES) | 2009-06-25 | — | — | WO | claimed |
| US-6733582-B1 | Brushite hydraulic cement stabilized with a magnesium salt | DR. H. C. ROBERT MATHYS STIFTUNG (CH) | 2004-05-11 | — | — | US | claimed |
| EP-1235599-B1 | BRUSHITE HYDRAULIC CEMENT STABILIZED WITH A MAGNESIUM SALT | ROBERT MATHYS STIFTUNG (CH) | 2003-07-23 | — | — | EP | claimed |
| EP-1235599-A1 | BRUSHITE HYDRAULIC CEMENT STABILIZED WITH A MAGNESIUM SALT | Dr.h.c. Robert Mathys Stiftung (CH) | 2002-09-04 | — | — | EP | claimed |
| US-6425949-B1 | Hydraulic surgical cement | DR. H. C. ROBERT MATHYS STIFTUNG (CH) | 2002-07-30 | — | — | US | claimed |
| CN-1083009-C | Process for synthesizing optically active cyanohydrin compound by oxynitrile cracking and enzyme catalysis of new enzyme source | SHANGHAI INST ORGANIC CHEM (CN) | 2002-04-17 | — | — | CN | claimed |
| EP-1023032-B1 | HYDRAULIC SURGICAL CEMENT | ROBERT MATHYS STIFTUNG (CH) | 2002-01-02 | — | — | EP | claimed |
| WO-2001041824-A1 | BRUSHITE HYDRAULIC CEMENT STABILIZED WITH A MAGNESIUM SALT | DR.H.C. ROBERT MATHYS STIFTUNG (CH) | 2001-06-14 | — | — | WO | claimed |
| EP-1023032-A1 | HYDRAULIC SURGICAL CEMENT | Dr.h.c. Robert Mathys Stiftung (CH) | 2000-08-02 | — | — | EP | claimed |
| CN-1243880-A | Process for synthesizing optically active cyanohydrin compound by oxynitrile cracking and enzyme catalysis of new enzyme source | SHANGHAI INST ORGANIC CHEM (CN) | 2000-02-09 | — | — | CN | claimed |
| WO-1999017710-A1 | HYDRAULIC SURGICAL CEMENT | DR. H.C. ROBERT MATHYS STIFTUNG (CH) | 1999-04-15 | — | — | WO | claimed |
| JP-63164884-A | — | — | None | — | — | JP | disclosed |
| US-4076852-A | MIXING CYSTEINE HYDROCHLORIDE, EGGS, THIAMINE HYDROCHLORIDE | INTERNATIONAL FLAVORS & FRAGRANCES INC. (US) | 1978-02-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120238521-A1 | Compositions and Methods for the Treatment of Musculoskeletal Related Diseases and Disorders Using Metal Ion-Citrate Analog Complexes | CS, ACLY, CA5A | ALDH1A1 1294/4885TSHR 1271/4885CYP2D6 3094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.